155 related articles for article (PubMed ID: 27189086)
1. A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study.
Matschke J; Müller-Beissenhirtz H; Novotny J; Vester I; Hertenstein B; Eisele L; Lax H; Ose C; Dührsen U
Acta Haematol; 2016; 136(2):101-7. PubMed ID: 27189086
[TBL] [Abstract][Full Text] [Related]
2. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Cheng Y; Wong RS; Soo YO; Chui CH; Lau FY; Chan NP; Wong WS; Cheng G
N Engl J Med; 2003 Aug; 349(9):831-6. PubMed ID: 12944568
[TBL] [Abstract][Full Text] [Related]
3. High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.
Wei Y; Ji XB; Wang YW; Wang JX; Yang EQ; Wang ZC; Sang YQ; Bi ZM; Ren CA; Zhou F; Liu GQ; Peng J; Hou M
Blood; 2016 Jan; 127(3):296-302; quiz 370. PubMed ID: 26480931
[TBL] [Abstract][Full Text] [Related]
4. [The efficacy and safety of 2 cycles' high-dose dexamethasone treatment adult primary immune thrombocytopenia].
Cui ZG; Wei Y; Hou M; Zhao HG; Wang HY
Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):401-3. PubMed ID: 21624223
[TBL] [Abstract][Full Text] [Related]
5. High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults.
Borst F; Keuning JJ; van Hulsteijn H; Sinnige H; Vreugdenhil G
Ann Hematol; 2004 Dec; 83(12):764-8. PubMed ID: 15309522
[TBL] [Abstract][Full Text] [Related]
6. High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis.
Mithoowani S; Gregory-Miller K; Goy J; Miller MC; Wang G; Noroozi N; Kelton JG; Arnold DM
Lancet Haematol; 2016 Oct; 3(10):e489-e496. PubMed ID: 27658982
[TBL] [Abstract][Full Text] [Related]
7. [Pulsed high-dose dexamethasone in resistant immune thrombocytopenic purpura].
Bulvik S; Ben-Tal O; Shimoni Z; Eldor A
Harefuah; 1996 Jul; 131(1-2):18-20, 71. PubMed ID: 8854471
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of high-dose dexamethasone with or without low-dose dexamethasone maintenance in untreated immune thrombocytopenia.
Din B; Wang X; Shi Y; Li Y
Acta Haematol; 2015; 133(1):124-8. PubMed ID: 25247485
[TBL] [Abstract][Full Text] [Related]
9. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
[TBL] [Abstract][Full Text] [Related]
10. Effect of high-dose dexamethasone in prednisone-resistant autoimmune thrombocytopenic purpura (ITP).
Dubbeld P; van der Heul C; Hillen HF
Neth J Med; 1991 Aug; 39(1-2):6-10. PubMed ID: 1961352
[TBL] [Abstract][Full Text] [Related]
11. First line treatment of adult patients with primary immune thrombocytopenia: a real-world study.
Wang L; Xu L; Hao H; Jansen AJG; Liu G; Li H; Liu X; Zhao Y; Peng J; Hou M
Platelets; 2020; 31(1):55-61. PubMed ID: 30744465
[TBL] [Abstract][Full Text] [Related]
12. Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience.
Mazzucconi MG; Fazi P; Bernasconi S; De Rossi G; Leone G; Gugliotta L; Vianelli N; Avvisati G; Rodeghiero F; Amendola A; Baronci C; Carbone C; Quattrin S; Fioritoni G; D'Alfonso G; Mandelli F;
Blood; 2007 Feb; 109(4):1401-7. PubMed ID: 17077333
[TBL] [Abstract][Full Text] [Related]
13. High-dose pulsed dexamethasone for immune thrombocytopenia.
Demiroğlu H; Dündar S
N Engl J Med; 1997 Aug; 337(6):425-7. PubMed ID: 9244850
[No Abstract] [Full Text] [Related]
14. Idiopathic thrombocytopenic purpura in pregnancy treated with pulsed high-dose oral dexamethasone.
Byrne JD; Incerpi MH; Goodwin TM
Am J Obstet Gynecol; 1997 Aug; 177(2):468-9. PubMed ID: 9290474
[TBL] [Abstract][Full Text] [Related]
15. Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial.
Mazzucconi MG; Rodeghiero F; Avvisati G; De Stefano V; Gugliotta L; Ruggeri M; Vianelli N; Fazi P; Paoloni F; Sargentini V; Baldacci E; Ferretti A; Martino B; Vincelli ID; Carli G; Fortuna S; Di Ianni M; Ranalli P; Palandri F; Polverelli N; Lugli E; Rivolti E; Patriarca A; Rago A; D'Adda M; Gentile M; Siragusa S; Sibilla S; Carella AM; Rossi E; Battistini R; Zaja F; Bocchia M; Di Renzo N; Musto P; Crugnola M; Giuffrida AC; Krampera M; Tafuri A; Santoro C
Blood Adv; 2024 Mar; 8(6):1529-1540. PubMed ID: 38231017
[TBL] [Abstract][Full Text] [Related]
16. High-dose cycles of dexamethasone in idiopathic thrombocytopenic purpura.
Calabresi AR; Veith RW; Rigby PG
J La State Med Soc; 2004; 156(5):269-72. PubMed ID: 15554097
[TBL] [Abstract][Full Text] [Related]
17. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy.
Andersen JC
N Engl J Med; 1994 Jun; 330(22):1560-4. PubMed ID: 8177245
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
19. Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia.
Li Z; Mou W; Lu G; Cao J; He X; Pan X; Xu K
Int J Hematol; 2011 Jan; 93(1):91-8. PubMed ID: 21188563
[TBL] [Abstract][Full Text] [Related]
20. High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.
Gómez-Almaguer D; Tarín-Arzaga L; Moreno-Jaime B; Jaime-Pérez JC; Ceballos-López AA; Ruiz-Argüelles GJ; Ruiz-Delgado GJ; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Sánchez-Cárdenas M
Eur J Haematol; 2013 Jun; 90(6):494-500. PubMed ID: 23470153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
